COMMUNIQUÉ DE PRESSE publié le 31/01/2023 à 14:00, il y a 3 années 1 mois Goodbody Health Progress Update: Phlebotomy Services
COMMUNIQUÉ DE PRESSE publié le 26/01/2023 à 14:00, il y a 3 années 1 mois Goodbody Health Partners with Datar to Offer Innovative Cancer Screening
Publié le 11/03/2026 à 17:45, il y a 23 minutes DAMARTEX / Résultats du premier semestre de l’exercice 2025/2026
Publié le 11/03/2026 à 17:44, il y a 24 minutes Publication of the 2025 Universal registration document
Publié le 11/03/2026 à 16:30, il y a 1 heure 38 minutes Star Copper Announces Closing of Oversubscribed Flow-Through Share Private Placement
Publié le 11/03/2026 à 15:55, il y a 2 heures 13 minutes Caledonia Mining Corporation Plc Notice of Q4 and FY 2025 Results and Investor Presentation
Publié le 11/03/2026 à 14:27, il y a 3 heures 41 minutes Faraday Copper Announces Closing of C$100 Million Offering with Participation by a Lundin Family Trust and BHP
Publié le 11/03/2026 à 14:00, il y a 4 heures 8 minutes Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
Publié le 11/03/2026 à 13:30, il y a 4 heures 38 minutes NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
Publié le 11/03/2026 à 17:40, il y a 28 minutes VALBIOTIS SA: Valbiotis annonce la tenue de son Assemblée générale mixte des actionnaires le 17 avril 2026
Publié le 11/03/2026 à 17:05, il y a 1 heure 3 minutes Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Publié le 11/03/2026 à 16:50, il y a 1 heure 18 minutes ParTec and BF exaQC Take Note of Largely Favorable but Dismissive First-Instance Ruling. A Pyrrhic Victory for NVIDIA?!
Publié le 11/03/2026 à 16:41, il y a 1 heure 27 minutes EQS-Adhoc: Knaus Tabbert AG publishes selected preliminary financial figures for the 2025 financial year
Publié le 11/03/2026 à 15:43, il y a 2 heures 25 minutes audius significantly exceeds 2025 annual targets / dynamic growth of 29% predominantly organic / very strong operating cash flow
